Article
Digoxin pharmacokinetics and MDR1 genetic polymorphisms.
European journal of clinical pharmacology - 1 Apr 2003
Verstuyft Céline, Schwab Mathias, Schaeffeler Elke, Kerb Reinhold, Brinkmann Ulrich, Jaillon Patrice, Funck-Brentano Christian, Becquemont Laurent
Abstract excerpt
BACKGROUND: The effect of MDR1 C3435T single nucleotide polymorphism (SNP) in exon 26 on digoxin pharmacokinetics has recently been challenged. OBJECTIVE. To clarify the relationships between MDR1 genetic polymorphisms in exon 26 (C3435T) and 21 (G2677T/A) and digoxin pharmacokinetics. MATERIALS AND METHODS: MDR1 genotypes for C3435T and G2677T/A SNPs were determined in 32 healthy subjects whose single oral dose...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
